Fig. 5From: Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studiesAdverse clinical outcomes associated specifically with 6 versus 12Â months DAPT use in patients with DMBack to article page